Obsessive-Compulsive Disorder (OCD) is a psychiatric condition with strong evidence for a genetic component and for the involvement of genes of the serotonin system. In a recent family-based association study we reported an association between the G allele of the G861C polymorphism of the 5HT1D␤ receptor gene and OCD. The aim of the present study was to further investigate for the presence of linkage disequilibrium between each of two polymorphisms of the 5HT1D␤ receptor gene and OCD in a larger sample of OCD families. In a total of 121 families the G861C and the T371G polymorphisms of the 5HT1D␤ receptor gene were genotyped using standard protocols. The genotyping data were analyzed with a new extension of the Transmission Disequilibrium Test (FBAT). The phenotypes considered in the analyses were the diagnosis of OCD and two quantitative phenotypes related to the diagnosis and clinically relevant, ie, the age at onset and the severity of OCD symptoms. We confirmed the previously found preferential transmission of the G861 allele to the affected subjects (z = Obsessive-Compulsive Disorder (OCD) is a severe psychiatric condition affecting up to 3% of the general population lifetime.
Obsessive-Compulsive Disorder (OCD) is a severe psychiatric condition affecting up to 3% of the general population lifetime. 1 The etiology of OCD remains obscure. However, there is strong evidence for a genetic component, 2 and for the involvement of the serotonin (5HT) neurotransmission. [3] [4] [5] The 5-HT1D␤ receptor is a terminal auto-receptor involved in the regulation of 5HT release. The acute administration of non-selective (ie, mCPP) or selective (ie, sumatriptan) ligands of the 5HT1D␤ receptor induces a transient worsening of OCD symptoms. 4, 6, 7 On the other hand, the chronic administration of sumatriptan was found to improve symptoms in some OCD patients resistant to conventional pharmacotherapy. 8 We recently reported on significant linkage disequilibrium between the G861 allele of the 5HT1D␤ gene and OCD. 9 The specificity of this association has been supported by a more recent study reporting no association between the same marker and bipolar disorder. 10 The confirmation of the role of the 5HT1D␤ gene in OCD will have important implications for the understanding of the pathogenesis of the disease and for the development of new therapeutic strategies.
In this article we present: (1) a confirmation of our previous finding on the G861C 11 polymorphism of the 5HT1D␤ gene; (2) the results of a linkage disequilibrium analysis on an additional functional polymorphism (T371C) 12, 13 of the gene; and (3) the results of the analysis of these two polymorphisms with respect to clinically relevant quantitative phenotypes related to OCD.
The main clinical and demographic characteristics of the sample of OCD subjects we studied (derived from a total of 121 families) are summarized in Table 1 . No significant differences in the variables considered were found between genders.
For the G861C polymorphism the genotype frequencies in the affected were: GG (63.1%), GC (31.2%), and CC (5.7%), following the Hardy-Weinberg equilibrium ( 2 = 0.775, df = 2, P = 0.379). For the T371C polymorphism the genotype frequencies were: TT (97.4%), TC (2.6%), and CC (0%), following Hardy-Weinberg equilibrium ( 2 = 0.026, df = 1, P = 0.871). The results of the family-based test for association in the presence of linkage disequilibrium (FBAT) 14, 15 performed considering the diagnosis of OCD as the affection trait are summarized in Table 2 . We found a preferential transmission of the G861 allele to the affected subjects (z = 2.262, P = 0.023). With respect to the T371C polymorphism, we found only five informative families in the whole sample. No significant biases in the transmission of either allele were found (z = 0.378, P = 0.705).
In the light of these results, we applied the FBAT procedure considering the age at onset of OCD and lifetime OCD symptom severity as the affection traits. In doing these analyses, we hypothesized that the G861 variant would be associated with an earlier age at onset of the disease and more severe lifetime OCD symptoms. The results of FBAT performed considering the age at onset of OCD and OCD symptoms severity, as scored by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), 16 as the affection traits are summarized in Table 3 . We report here the analyses done on the G861C polymorphism only, as the number of informative families for the T371C polymorphism was too small to provide any significant result. The obsession severity score was higher in subjects carrying the G861 allele from their parents, but this trend did not reach the threshold for the statistical significance (z = 1.812, P = 0.070). No significant association was found between the polymorphism and the other quantitative phenotypes considered (Table 3) .
These results confirm the previously reported significant linkage disequilibrium between the G861C polymorphism of the 5HT1D␤ receptor gene and OCD, with a preferential transmission of the G allele to the affected subjects. The present study represents a major extension of our previous report, 9 in which we investigated a sample with a smaller size and a more limited variety of family constellations (ie, parent-offspring triads and sib-ships with one unaffected sibling), on which we applied the TDT/sib-TDT procedure. 17 Investigating for the presence of linkage disequilibrium has been considered a particularly useful strategy in identifying genes that may contribute to disease susceptibility in complex traits. 18 Several methods for the detection of linkage disequilibrium are now available. The TDT and its extension to discordant sib-ships 17 use both data from families in which marker genotypes are known from the parents and the proband, and data from families where the parent genotypings are missing but the genotyping of one unaffected sibling is available. The TDT examines alleles preferentially transmitted from the parents to the affected offspring while the sib-TDT compares the marker genotypes in affected and unaffected siblings. Even though this procedure has been considered quite efficient, it is not suitable for samples composed of families with multiple affected, where, as an example, the information carried by the affected siblings would not be taken into account, decreasing the efficiency of the analysis performed. More recently, a new unified approach for testing association in the presence of linkage using any type of family configuration and any type of phenotype (either qualitative or quantitative) has been developed. 14, 19 As our new sample was composed of a number of families with multiple affected siblings (23%), we applied this new procedure that allowed us to use all the information contained in our sample despite the variety of family constellations.
The results of the analyses we did on the quantitative traits related to OCD with respect to the G861C polymorphism of the 5HT1D␤ deserve some comment. The analysis of quantitative traits continuously distributed within the population, as opposed to the study of categorical traits, has been identified as a more powerful strategy in detecting genetic susceptibility to complex diseases. [20] [21] [22] In our exploratory analysis of some quantitative phenotypes related to OCD, we did not find any clear association between the age at onset of the disease and the G861C polymorphism of the 5HT1D␤ receptor gene. For the purpose of this study the age at onset of OCD in the affected was defined as the age when the patient first met the DSM-IV criteria for OCD. However, there is no consensus to date on the most valid and appropriate definition of the age at onset of OCD for genetic studies. Measures including the age when the subject experienced the first sub-clinical OCD symptoms or the age when the subject first visited a physician for treatment have been proposed as valid complementary measures for an accurate assessment of this relevant phenotype. To date, there are no studies we are aware of, supporting the idea that these different measures will provide more useful information. In fact, most of the recent studies have used as a measure of the age at onset of OCD the same measure we used, ie, the age when the patient first met the standardized diagnostic criteria for the disease. [23] [24] [25] With respect to the severity of OCD symptoms, we found that patients carrying the G861 allele had higher lifetime Y-BOCS obsession scores. However, this trend did not reach the threshold for statistical significance. The assessment of OCD symptom severity was done retrospectively and was based on the recollection of the patients of the two consecutive weeks when their symptoms were most severe during the course of the illness. We chose this approach, as opposed to scoring the severity of OCD symptoms at the time of the clinical assessment for this study, to avoid possible biases due to the current treatment status of the patients. In fact, the presence of ongoing pharmacological or behavioral treatment was not an exclusion criterion for our genetic study. The possibility that a lack of accuracy in the patient recollection of their symptom severity may have influenced our results cannot be excluded. On the other hand, it is possible that OCD symptom severity per se is not a meaningful quantitative trait for the description of the complex OCD pheno-
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type. In fact, recent studies have pointed out that the clinical phenomenology and the symptom structure of OCD is complex and heterogeneous. On the basis of the Y-BOCS symptom checklist, four separate symptom dimensions have been identified as valid descriptors of the OCD phenotypes across different studies. 22, 26, 27 Preliminary investigations have provided support for the reliable use of these symptom dimension subscores in genetic studies. 28 However, a validated instrument for the specific assessment of these OCD symptom dimensions is not available yet and even though the use of these dimensions as alternative phenotypes appears to be promising, their hereditability needs to be established.
In conclusion, according to the results from this and previous studies, the G861C polymorphism of the 5HT1D␤ receptor gene appears to be specifically implicated in the pathogenesis of OCD, with the G variant conferring an increased risk of developing the disease. It may be hypothesized that the 5HT1D␤ receptor gene is associated with a specific sub-phenotype related to OCD as opposed to the DSM-IV category. 29 Studies on the expression of the different gene variants together with more sophisticated definition of quantitative phenotypes related to OCD are warranted. The effect of the polymorphism in predicting the response to antiobsessional medication and the use of the pharmacological response as a phenotype of interest for genetic studies on this receptor appear to be particularly promising.
Subjects and Methods

Sample and assessment
One hundred and twenty-one probands were selected from consecutive referrals to the Anxiety Disorders
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Clinic at the Centre for Addiction and Mental Health. To be eligible for the study patients had to have either the biological parents or at least one sibling living and willing to participate. Diagnoses on all patients and their siblings were assessed by a structured interview for DSM-IV criteria (SCID-I). The SCID-I were administered by trained interviewers blind with respect to the genotypes of the probands, and then reviewed by experienced psychiatrists in the diagnosis and treatment of OCD and related conditions.
Patients with a history of neurological or metabolic diseases, bipolar, schizophrenia, schizoaffective disorders, or with a current diagnosis of substance dependence were excluded. Out of the 121 families we recruited for this study, 79 were parent-proband triads, 28 were parent-proband triads with one or more affected siblings, and 14 were sib-ships with one unaffected subject, leading to a total of 157 OCD patients. The sample included the 67 OCD subjects analyzed in our previous study. 9 One hundred and seventeen families were of European Caucasian origin (96.7%), and four were Asian (3.3%). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) 16 was administered to all the affected subjects to assess the lifetime severity of OCD symptoms. The assessment of the lifetime severity of OCD symptoms was based on the patient recollection of the period of time, since the onset of the illness, when they had experienced the most severe OCD symptoms for two consecutive weeks. In addition, we recorded for each affected individual, the age at onset of OCD, defined as the age when the patient first fulfilled the DSM-IV diagnostic criteria for the disease.
From all the subjects (probands, siblings, and their parents) written informed consent to participate in the study, which included the use of personal and clinical data and blood drawing for genotyping, had been obtained.
Genotyping
Genomic DNA was extracted from whole blood with a non-enzymatic procedure. 30 (a) G861C This polymorphism of the 5HT1D␤ gene was genotyped according to the procedure described by Lappalainen et al. 12 The 548-bp PCR fragment of 5HT1D␤ was amplified using a reaction mixture as follows: 150 ng of genomic DNA, 0.6 M of each of the primers, 5HT1B-A (5Ј-gaa aca gac gcc caa cag gac-3Ј) and 5HT1B-B (5Јg-cca gaa acc gcg aaa gaa gat-3Ј), 1.0 mM magnesium chloride (MgCl 2 ), 0.2 mM dNTP, and 1 unit of Taq polymerase, with a total reaction volume of 25 l. An initial denaturation step for 3 min at 95°C was followed by 30 cycles of denaturing at 95°C for 30 s, annealing at 57°C for 30 s, and an extension of 72°C for 30 s. The last cycle was then followed by a final extension step of 72°C for 7 min. All the PCR product was digested with 5 units of HincII restriction enzyme (New England Biolabs, Mississauga, ON, Canada) per reaction at 37°C overnight. The alleles were detected after separation on a 2.5% agarose gel for 1 h, and the G allele was the undigested fragment.
(b) T371G (Phe-124-Cys) This polymorphism was genotyped using the procedure described by Nö then et al. 13 The 258-bp PCR fragment of 5HT1D␤ was amplified using a reaction mixture of 150 ng of genomic DNA, 0.8 M of each of the primers, 5HT1B-F (5Ј-ccc tac cct gga aag tac tgc-3Ј) and 5HT1B-RM (5Ј-tga tgt ccg acg aca gct ag-3Ј), 1.5 mM magnesium chloride (MgCl 2 ), 0.2 mM dNTP, and 1 unit of Taq polymerase, with a total reaction volume of 25 l. Amplification of this fragment was done using the PCR conditions as follows: an initial denaturation step for 5 min at 94°C, followed by 35 cycles of 94°C for 30 s, annealing at 62°C for 20 s and elongation at 72°C for 30 s. After the last cycle, a final extension step at 72°C for 10 min was proceeded. Ten l of the PCR product was digested with 2.5 units of NheI restriction enzyme (New England Biolabs, Mississauga, ON, Canada) per reaction and 3 l of 10 × buffer Y + /Tango (MBI Fermentas, Burlington, ON, Canada) at 37°C overnight. The alleles were separated on a 3.5% high-resolution agarose gel for approximately 2.5-3 h. The T allele was the undigested band, while the G allele consisted of two bands of 238 bp and 20 bp.
Statistical analyses
Clinical variables including the mean age at the time of the assessment, the age at onset of OCD, the presence of comorbid Axis I disorders, and the lifetime severity of OCD symptoms were tabulated for all the OCD probands and their affected siblings. These main clinical variables were also compared between genders. Student's t-tests were used for the continuous variables while chi-square tests were used for the categorical ones. All these analyses were done using the SPSS for Windows software (version 10.1).
Our sample included parent-proband triads, extended families with one or more affected siblings, and sib-ships with one unaffected subject. Given this heterogeneous sample composition, the classical Transmission Disequilibrium Test (TDT) was not the most suitable procedure to analyze our genotyping data. The classical TDT is not applicable to extended families, since marker genotypes among siblings are correlated in linked regions. Thus, we decided to use a new procedure, which tests for association in the presence of linkage and generalizes the TDT to any type of family and to any type of phenotypes. 15, 20 The software we used (FBAT) 16 allowed the analysis of both qualitative and quantitative traits. We applied FBAT to the 5-HT1D␤ markers genotyped, considering both categorical phenotypes (diagnosis of OCD) and clinically relevant quantitative phenotypes, ie, the age at onset of OCD, and the lifetime Y-BOCS total, obsession, and compulsion sub-scores. All the analyses were done under the condition of an additive model.
